Renhe Pharmacy Co., Ltd. Class A

As of March 31, 2026, Renhe Pharmacy Co., Ltd. Class A carries a market capitalization of 8.04B, placing it among publicly traded companies globally. Its enterprise value stands at 4.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Renhe Pharmacy Co., Ltd. Class A's next confirmed earnings release is scheduled for October 27, 2026.

As of March 31, 2026, Renhe Pharmacy Co., Ltd. Class A has 1.40B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Renhe Pharmacy Co., Ltd. Class A maintains a current ratio of 6.58, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Renhe Pharmacy Co., Ltd. Class A recorded 149.24M in income tax expense.

As of the close on October 23, 2026, Renhe Pharmacy Co., Ltd. Class A's stock has declined approximately 19.08% over the past 52 weeks. The 50-day moving average sits at 5.32, while the 200-day moving average is 5.57.

As of March 31, 2026, Renhe Pharmacy Co., Ltd. Class A holds 3.99B in cash and equivalents against 2.24M in total debt, resulting in a net debt position of -1.01B. Total book value stands at 6.46B, with working capital of 4.37B providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Renhe Pharmacy Co., Ltd. Class A's most recent stock split took place on May 26, 2015 with a 4:5 split ratio.